TABLE 3.

Cox proportional hazards model evaluating cancer‐specific survival for all patients diagnosed with colorectal cancer among antihypertensive and non‐hypertensive medication users (N = 13,982)

	Hazard† Ratio (95%CI)*
Antihypertensive users	0.79 (0.75 to 0.83)
ACEI users	0.84 (0.80 to 0.87)
ARB users	0.96 (0.89 to 1.03)
BB users	0.87 (0.84 to 0.91)
TD users	0.83 (0.80 to 0.87)

^† Adjusted for age, sex, marital status, race and/or ethnicity, chemotherapy, surgery, stage, grade, metformin, diabetes, Charlson comorbidity index, monotherapy, hypertension, cancer type, radiation.

^*ACEI, angiotensin‐converting enzyme inhibitors; ARB, angiotensin II receptor blocker; BB, beta‐blockers; CI, confidence interval; TD, thiazide diuretics.